Screener
Supernus Pharmaceuticals SUPN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 199,372 | 180,222 |
| Accounts receivable, net | 182,183 | 187,802 |
| Inventories, net | 87,062 | 82,385 |
| Prepaid expenses and other current assets | 78,094 | 65,325 |
| Total current assets | 731,580 | 644,182 |
| Restricted cash | 1,450 | 1,450 |
| Property and equipment, net | 10,042 | 10,531 |
| Intangible assets, net | 549,712 | 569,456 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Supernus Pharmaceuticals's prepaid & other current?
- Supernus Pharmaceuticals (SUPN) reported prepaid & other current of $78.09M in Q1 2026.
- How has Supernus Pharmaceuticals's prepaid & other current changed year-over-year?
- Supernus Pharmaceuticals's prepaid & other current increased by 169.9% year-over-year, from $28.93M to $78.09M.
- What is the long-term trend for Supernus Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's prepaid & other current has grown at a 28.4% compound annual growth rate (CAGR), from $18.68M to $65.33M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Supernus Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude